Christina Godfried Sie

3PUBLICATIONS
35CO-AUTHORS
Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 13, 2026
Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

|Mar 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.

Maria Vieito, Elisa Fontana, Catherine H Han

|May 18, 2022
Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis.

Ester Bonfill-Teixidor, Raffaella Iurlaro, Cornelia Handl

Pageof 1

Frequent Collaborators

3 joint publications

Gabriel Schnetzler

2 joint publications

Eduardo Castañón Álvarez

2 joint publications

Oliver Bechter

2 joint publications

Catherine H Han